Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (3451)	10/24/2003 9:56:07 PM
From: Ken W	Read Replies (1) \| Respond to of 23958

Texas Dude DSCO certainly is an interesting company, going forward..., of course there is a "however" attached to that statement. After reading your posts regarding the potential for the company, they are still several months to 2 years away from commericalization of the product, correct? Other than the intent to commericalize the product, what is it that you feel will drive the stock higher than the present range? Technically, I noted that the stock has been in a beautiful trading range between 7 and 8 over the last 4 to 6 months, however, (again) that range looks to be broken to the downside due to the general weakness in the overall market. As stated in the opening heading of our little niche here we are looking for things that will be a catalyst to drive the stock higher....In the case of some of our stocks it is purely earnings. Others are recurring rev's due to patents held and licensing fees due. Others are due to an upcoming event that is expected within the next 6 to 9 months. I realize that this time frame is somewhat short sighted given the histroy of the stock market, but it is not the market it used to be and, quite frankly most of us here don't have 5 to 10 years to wait. LOL Ken

To: Arthur Radley who wrote (3451)	10/27/2003 3:40:22 AM
From: Gulo	Read Replies (4) \| Respond to of 23958

Surfaxin has been shown to remove inflammatory and infectious infiltrates from patients' lungs If that is what you mean by an anti-inflammatory drug, I think your definition is more than a bit too broad. My point is that there is no reason to suspect the drug in the article is Surfaxin and that trying to draw a connection is intellectually dishonest. Perhaps the confusion is around the definition of a surfactant. A surfactant is a substance that has two distinct ends to each molecule, generally one that is water soluble and one that is not. An example is soap. The non-water-soluble ends stick to dirt, oil or whatever, leaving the water soluble ends to the outside, like fuzz glued to a tennis ball. The resulting water-soluble layer around the particle that allows it to be dispersed in water. Lung surfactants allow the lung lining to remain moist and clean while breathing. They wash away inhaled junk like soap washes away dirt. Sure, keeping wet and clean is a good way to prevent or limit inflammation, but that does not in any way entitle Surfaxin to be called an anti-inflammatory. In fact, technically, it is not even a drug. That said, surfaxin could be an interesting treatment if the cost is low enough. There are a number of reasons, as you pointed out, to switch from animal surfactants. -g